SCHEMBL9200433

SCHEMBL9200433

CNc1c(C(=O)N(C)c2ccccc2)c(=O)n(C)c2ccc(SC)cc12

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ PGR P06401 1/20 0.55
▸ SRC P12931 4/20 0.50
▸ TP53 P04637 2/20 0.37
▸ HIF1A Q16665 2/20 0.36
▸ EGFR P00533 3/20 0.36
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9202310 0.86 MEN1 (0.71) MEN1KMT2APGRSRCTP53
SCHEMBL9194924 0.86 MEN1 (0.58) MEN1KMT2APGRSRCTP53
SCHEMBL9288974 0.85 MEN1 (0.57) MEN1KMT2APGRSRCTP53
SCHEMBL9202124 0.85 MEN1 (0.57) MEN1KMT2APGRSRCTP53
SCHEMBL10677667 0.84 KMT2A (0.71) MEN1KMT2APGRSRCTP53
SCHEMBL10671530 0.83 MEN1 (0.55) MEN1KMT2APGRSRCTP53
SCHEMBL9199188 0.83 MEN1 (0.55) MEN1KMT2APGRSRCTP53
SCHEMBL10671773 0.79 MEN1 (0.54) MEN1KMT2APGRSRCTP53
SCHEMBL9712311 0.78 MEN1 (0.58) MEN1KMT2APGRSRCTP53
SCHEMBL9287479 0.78 MEN1 (0.58) MEN1KMT2APGRSRCHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639182-A1 QUINOLINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 — — EP disclosed
WO-1992018483-A1 QUINOLINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-10-29 — — WO disclosed
Send feedback